🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 4 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/07/2025 | 120,68 | 127,07 | 120,68 | 126,92 | +4,29% | 5,29% | 140.900 |
| 11/07/2025 | 124,52 | 124,52 | 120,74 | 121,70 | -2,62% | 3,04% | 106.500 |
| 10/07/2025 | 121,50 | 126,24 | 121,25 | 124,98 | +2,11% | 4,11% | 183.400 |
| 09/07/2025 | 116,60 | 124,62 | 116,44 | 122,40 | +6,32% | 7,02% | 194.000 |
| 08/07/2025 | 114,46 | 116,70 | 114,00 | 115,12 | +1,20% | 2,36% | 114.500 |
| 07/07/2025 | 113,82 | 114,86 | 112,83 | 113,76 | -0,72% | 1,78% | 98.800 |
| 03/07/2025 | 113,33 | 114,79 | 112,41 | 114,58 | +0,81% | 2,10% | 52.100 |
| 02/07/2025 | 113,28 | 114,68 | 111,72 | 113,66 | +0,98% | 2,61% | 106.500 |
| 01/07/2025 | 112,42 | 115,53 | 112,11 | 112,56 | -0,99% | 3,04% | 109.700 |
| 30/06/2025 | 115,38 | 115,38 | 113,27 | 113,68 | -0,41% | 1,83% | 111.400 |
| 27/06/2025 | 116,18 | 116,18 | 112,77 | 114,15 | -1,33% | 2,94% | 327.900 |
| 26/06/2025 | 116,48 | 116,61 | 113,33 | 115,69 | -0,03% | 2,82% | 159.400 |
| 25/06/2025 | 118,25 | 118,25 | 115,66 | 115,72 | -2,11% | 2,19% | 146.600 |
| 24/06/2025 | 115,97 | 118,58 | 114,18 | 118,22 | +2,82% | 3,79% | 137.200 |
| 23/06/2025 | 113,80 | 115,10 | 110,00 | 114,98 | +0,80% | 4,48% | 115.200 |
| 20/06/2025 | 114,94 | 114,94 | 112,42 | 114,07 | -0,50% | 2,19% | 259.200 |
| 18/06/2025 | 112,00 | 115,54 | 112,00 | 114,64 | +1,87% | 3,16% | 144.700 |
| 17/06/2025 | 113,68 | 116,16 | 111,88 | 112,54 | -2,15% | 3,76% | 123.700 |
| 16/06/2025 | 112,95 | 115,26 | 112,05 | 115,01 | +2,23% | 2,84% | 96.500 |
| 13/06/2025 | 112,41 | 113,72 | 110,18 | 112,50 | -1,70% | 3,15% | 83.300 |
| 12/06/2025 | 114,76 | 115,89 | 113,60 | 114,45 | -0,81% | 2,00% | 121.700 |
| 11/06/2025 | 113,42 | 116,40 | 112,67 | 115,39 | +1,74% | 3,29% | 183.800 |
| 10/06/2025 | 109,49 | 114,95 | 106,30 | 113,42 | +3,60% | 7,90% | 166.200 |
| 09/06/2025 | 106,49 | 109,77 | 103,43 | 109,48 | +3,29% | 5,95% | 121.900 |
| 06/06/2025 | 104,62 | 106,70 | 103,68 | 105,99 | +1,74% | 2,89% | 91.800 |
| 05/06/2025 | 103,96 | 104,38 | 102,50 | 104,18 | +0,37% | 1,81% | 81.800 |
| 04/06/2025 | 102,00 | 103,98 | 101,67 | 103,80 | +1,42% | 2,26% | 129.300 |
| 03/06/2025 | 101,30 | 102,95 | 101,30 | 102,35 | +0,70% | 1,63% | 83.200 |
| 02/06/2025 | 102,51 | 103,79 | 100,67 | 101,64 | -0,54% | 3,04% | 99.900 |
| 30/05/2025 | 100,29 | 104,01 | 98,89 | 102,19 | +1,27% | 5,11% | 164.200 |